CDK9-IN-7
Catalog No.
BA2986
CDK9-IN-7 is a highly potent and selective, orally active inhibitor.
Featured Products
CDK9-IN-7 is a highly potent and selective, orally active inhibitor (=11nM).CDK9-IN-7 exhibits anticancer activity without significant toxicity.CDK9-IN-7 induces apoptosis in non-small-cell lung cancer (NSCLC) cells, blocks the cell cycle in G2 phase, and possesses inhibitory properties against NSCLC stem cells.CDK9-IN-7 is a potent and selective, orally active inhibitor (=11nM).CDK9-IN-7 is a potent and selective inhibitor of CDK9-IN-7.CDK9-IN-7 exhibits anticancer activity with no apparent toxicity.
| Physical Appearance | A solid |
| Storage | -20°C |
| M.Wt | 547.71 |
| Cas No. | 2369981-71-3 |
| Formula | C29H37N7O2S |
| Shipping Condition | Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice. |
| General tips | We do not recommend long-term storage for the solution, please use it up soon. |